Repozytorium
Wyszukaj
Kolekcje
Inne
Molecular modeling study of leflunomide and its active metabolite analogues.
Autorzy
Rok wydania
2005
Czasopismo
Journal of Chemical Information and Modeling
Numer woluminu
45
Strony
39-48
DOI
10.1021/ci049754d
Kolekcja
Język
Angielski
Typ publikacji
Artykuł
Leflunomide is known as a compound with various sorts of biological activity, which found a practical application in medicine. Search of current literature revealed an active metabolite of Leflunomide together with its eight analogues synthesized as protein tyrosine kinase inhibitors with potential anticancer activity. Accurate description of the molecular structure of these compounds is valuable. The detailed geometrical parameters description was performed using DFT theory. The conformational analysis and intramolecular proton transfer were considered. Using the most stable conformation the detailed electronic structure description was obtained by analysis of electron density and electrostatic potential distribution in the first step. Next, the topological analysis of the electron density by AIM method and electron localization function (ELF) theories supplemented this study. The AIM and ELF theories were applied to study the topology of the molecules, atomic charges distribution, and details of bonding. The theoretical investigations were performed in the gas phase and by using SCRF/PCM solvent reaction field. In this study the molecular modeling results for Leflunomide and the analogues of its active metabolite are presented.
Adres publiczny
http://dx.doi.org/10.1021/ci049754d
Strona internetowa wydawcy
Podobne publikacje
Pharmacological profile and molecular modeling of cyclic opioid analogues incorporating various phenylalanine derivatives.
Adamska-Bartłomiejczyk Anna, Lipiński Piotr F. J., Piekielna-Ciesielska Justyna, Kluczyk Alicja, Janecka Anna
Novel biological effects of alloferon and its selected analogues: structure-activity study.
Kuczer Mariola, Czarniewska Elżbieta, Rosiński Grzegorz
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.
Tayeb-Bel Hay H., Salerno Milena, Priebe W., Kozłowski Henryk, Garnier-Suillerot A.